[{"from": "human", "value": "Could you provide a description of this molecule? [C][N][C][C][C][Branch1][Branch1][C][C][Ring1][=Branch1][N][C][=Branch1][C][=O][C][=C][C][=Branch2][Branch1][Ring1][=C][Branch1][=Branch1][C][=C][Ring1][=Branch1][F][N][C][=N][C][=C][Branch2][Ring1][O][C][=Branch1][Ring2][=N][Ring1][=Branch1][O][C][=C][C][=C][C][=C][Ring1][=Branch1][C][=Branch1][C][=O][N][Branch1][Ring2][C][Ring1][=Branch1][C][C][Branch1][C][F][Branch1][C][F][F][O][C]"}, {"from": "gpt", "value": "The molecule is an orally bioavailable inhibitor of the non-receptor, cytoplasmic tyrosine kinase protein tyrosine kinase 2 (focal adhesion kinase 1; FAK1; FAK: PTK2) with potential antineoplastic activity. Upon oral administration, IN10018 targets and inhibits, in an adenosine triphosphate (ATP)-competitive manner, PTK2. This prevents PTK2-mediated downstream signaling and inhibits migration, proliferation, invasion, and survival in PTK2-overexpressing tumor cells. The cytoplasmic tyrosine kinase PTK2, a signal transducer for integrins overexpressed in various tumor cell types, is involved in tumor cell invasion, migration and proliferation."}]